BNC Wealth Management’s AbbVie ABBV Stock Holding History

BNC Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$264K	Sell	1,008 -47	-4%	-$12K	0.06%	91
2026 Q2	$265K	Sell	1,055 -17	-2%	-$3.66K	0.06%	90
2026 Q1	$233K	Sell	1,072 -16	-1%	-$3.55K	0.06%	96
2025 Q4	$249K	Hold	1,088	–	–	0.06%	89
2025 Q3	$252K	Sell	1,088 -2	-0.2%	-$407	0.06%	89
2025 Q2	$202K	Hold	1,090	–	–	0.06%	96
2025 Q1	$228K	Buy	+1,090	New	+$212K	0.08%	86
2024 Q4	–	Sell	-1,101	Closed	-$217K	–	97
2024 Q3	$217K	Buy	+1,101	New	+$205K	0.08%	86
2024 Q2	–	Sell	-1,126	Closed	-$205K	–	100
2024 Q1	$205K	Buy	+1,126	New	+$194K	0.09%	97
2023 Q2	–	Sell	-1,261	Closed	-$201K	–	100
2023 Q1	$201K	Buy	1,261 +5	+0.4%	+$764	0.11%	103
2022 Q4	$203K	Buy	+1,256	New	+$193K	0.12%	100
2020 Q4	–	Sell	-823	Closed	-$72K	–	97
2020 Q3	$72K	Buy	+823	New	+$77.5K	0.05%	139

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

BNC Wealth Management's ABBV Position: Q3 2026 in Review

BNC Wealth Management reduced its AbbVie (ABBV) stake by 4.5% in Q3 2026, selling an estimated $12K and leaving 1,008 shares worth $264K. The position accounts for 0.06% of the portfolio, ranked #91.

BNC Wealth Management first reported a position in ABBV in Q3 2020 and has held it in 12 quarters since. The position peaked at $265K in Q2 2026. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

BNC Wealth Management held 1,008 shares of AbbVie worth $264K as of Q3 2026.
BNC Wealth Management sold 47 AbbVie shares in Q3 2026, an estimated $12K.
AbbVie made up 0.06% of BNC Wealth Management's portfolio in Q3 2026, its #91 holding.
BNC Wealth Management first reported a position in AbbVie in Q3 2020 and has held it in 12 quarters since.
BNC Wealth Management's AbbVie position peaked at $265K in Q2 2026.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BNC Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.